USPTO 2015–2025 USPTO PatentsView US Corporation

CAS Medical Systems, Inc.

USPTO PatentsView assignee record - 13 granted patents across 5 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, CAS ranks #20,894 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 5 technology areas.

#20,894
of 49,997 US assignees by volume
15th percentile
by Innovation Score (24.4/100)
12.4
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20894 · US Corporation #20,894 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 13 grants
  • MID-PACK #20,894/49,997
  • PHOTO-FINISH Camilla IP PTY
  • CPC-NARROW A61B · 5 areas
  • INNOV-THIN 24.4/100
  • CLAIMS-RICH 12.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Camilla IP PTY Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How CAS’s 24.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around CAS

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows CAS's Innovation Score is 24.4/100 (15th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for CAS?

Each dot is one of CAS’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). CAS’s own 12.4 claims/patent is at or below the 14.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

CAS vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 010203040 Granted patents (volume) Avg claims / patent Camilla IP PTY Ltd - 13, 1Camilla IP PTYCanadian Blood Services - 13, 17.85Canadian Blood Se…Caringo, Inc. - 13, 28.85CaringoCarnival Corporation - 13, 14.69CarnivalCassina S.P.A. - 13, 1Cassina S P ACell Biotech Co., Ltd. - 13, 6.62Cell BiotechCenter FOR Advanced Soft Electronics - 13, 15.15Center FOR Advanc…Centipede Semi Ltd. - 13, 28.69Centipede SemiCAS Medical Systems, Inc. - 13, 12.38CAS Medical Syste…
CAS vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where CAS's grants concentrate

CAS Medical Systems, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2017 (4 grants) versus a trough of 2 in 2015. By volume, CAS sits between Camilla IP PTY Ltd and Centipede Semi Ltd..

Who files at CAS's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows CAS holds 13 patents at rank #20,890, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near CAS

By rank, the assignees closest to #20,890 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in CAS's primary technology class.

CAS's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 15th percentile higher than 15% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1.522.533.544.5 20152016201720182019 2
USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
CAS Medical Systems, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 15.4%
2016 2 15.4%
2017 4 30.8%
2018 3 23.1%
2019 2 15.4%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

CAS Medical Systems, Inc.'s patent record in context - here's where to go next.

  • CAS Medical Systems, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #20,894 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare CAS Medical Systems, Inc. against Camilla IP PTY Ltd, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 24.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.